Skip to main content
. 2009 Mar 2;27(10):1675–1684. doi: 10.1200/JCO.2008.18.2717

Table 5.

Clinical AEs (possible, probable, or definite attribution to the drug)

AEs Grade 1 and 2 AEs
Grade 3 AEs
Arm A
Arm B
Arm A
Arm B
No. % No. % No. % No. %
No. of patients 19 37 19 37
Constitutional
    Fatigue 14 74 23 62 2 11 7 19
    Weight loss 11 58 32 89 1 5 2 5
    Anorexia 11 53 21 57
    Taste changes 4 21 8 22
GI
    Ileus 1 3
    Colon perforation 1 5
    Diarrhea 15 79 25 68 1 5 1 3
    Stomatitis 2 11 6 17 1 5
    Pain tongue or tooth 2 11 5 14 1 5
    Pain abdomen or rectal 17 89 18 49 1 5 2 6
    Nausea 10 53 21 58
    Vomiting 7 37 3 8
    Heartburn 7 37 15 42
    Flatulence 15 79 24 65
    Dry mouth 1 5 2 6
Musculoskeletal
    Proximal myopathy 1 5
    Hand-foot skin reaction 11 58 20 56 2 11 2 5
    Back pain 4 11 1 5 1 3
    Chest pain 1 5 3 8 4 11
    Scalp pain 5 26 8 22 1 3
    Pain (general) 2 11 5 14 1 5 1 3
    Hand or foot pain 14 74 12 33 1 5 6 16
    Arthralgia 13 68 21 58 1 5 5 14
    Myalgia 2 11 4 11
    Muscle cramps 10 53 10 28
Dermatologic
    Skin rash 14 74 28 76 1 5 1 3
    Flushing 6 32 12 32
    Brown skin spots 3 16 6 16
    Dry skin 16 84 31 84
    Pruritis 15 79 28 75
    Nail changes 13 68 20 54
    Skin sores 4 21 2 5
    Alopecia 15 79 29 78
Vascular
    Hypertension 8 42 14 38 1 5 1 3
    Hemoptysis 1 5 1 3 0 2 6
    Epistaxis 1 5 1 3
    Retinal hem/vein occlusion 1 5 1 3
    Gum bleeding 0 1 3
    Tumor bleeding 0 1 3
    Wound healing (slow) 0 1 3
Cardiac
    Left ventricular dysfunction 0 1 3
    Atrial fib or SVT 0 2 6 0 1 3
    Sinus bradycardia 0 1 3
    Palpitation 1 5 2 6
Neurological
    Syncope 0 1 3
    Anxiety 0 1 3
    Dizziness 2 11 5 14
    Headache 3 16 6 17
    Neuropathy (sensory) 4 21 8 22
Respiratory
    Cough 0 1 3
    Dyspnea 3 16 5 14
    Hoarseness 2 11 2 6
Endocrine changes
    Irregular menses 0 2 6
Infection
    Infection 0 2 6 1 3
    Abscess 2 11 0
    Osteomyelitis-actinomycosis 0 1 3
Other tumors
    Acute myeloid leukemia 1 5 0
    Keratocanthoma 0 2 5

NOTE. Worst grade experienced by patient on study is counted in the above table. Please see text for grade 4-5 AEs.

Abbreviations: AE, adverse event; SVT, supraventricular tachycardia.